14beta-4'-Chlorocinnamoylaminodihydronormorphinone (2a), and analogues, are selective pseudoirreversible antagonists of the mu opioid receptor (MOR). The preparation of analogues with ethynic bonds, replacing the ethenic bond of 2a, is described. The new ligands, in mouse antinociceptive assays, had pseudoirreversible MOR antagonist activity, which, in the case of 8b was of longer duration than that of 2a. The related codeinone (9b) had only antagonist activity in vivo, in contrast to 2a's codeinone equivalent 3a, which had potent antinociceptive activity.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2788771PMC
http://dx.doi.org/10.1021/jm901074aDOI Listing

Publication Analysis

Top Keywords

opioid receptor
8
antagonist activity
8
14beta-arylpropiolylamino-17-cyclopropylmethyl-78-dihydronormorphinones opioids
4
opioids examples
4
examples pseudoirreversible
4
pseudoirreversible opioid
4
receptor antagonists
4
antagonists 14beta-4'-chlorocinnamoylaminodihydronormorphinone
4
14beta-4'-chlorocinnamoylaminodihydronormorphinone analogues
4
analogues selective
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!